Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
agricultural and biological sciences
Prevalence and genotype characterization of Human Papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso
Acta Tropica, Volume 117, No. 3, Year 2011
Notification
URL copied to clipboard!
Description
Background: Approximately, 15-20 of 40 HPVs that infect the female genital tract confer a high-risk of invasive cancer, thus HPVs account for 95% of cervix cancers. The objectives of this study were to: (i) estimate the prevalence of HPV infection in women infected with HIV in Ouagadougou, (ii) identify potential carcinogenic HPV strains and (iii) determine whether existing HPV vaccines match the isolated strains. Methods: From May 2009 to April 2010, 250 HIV-infected women were included in this study. Each woman was screened for the presence of HPV and for HPV genotype using PCR/hybridization technique. Results: Of the 250 HIV-infected women, 59.6% were infected with at least one type of HPV. High-risk HPVs were identified with the following prevalence: HPV-18 (25.0%); HPV-50'S (25.5%); HPV-30'S (20.8%); HPV-16 (4.7%); HPV-45 (3.7%). Low-risk HPVs were represented by HPV-6 (5.7%) and HPV-11 (0.9%). Conclusion: The issue of the study showed that the existing vaccines: Gardasil and Cervarix may be used in the country although they match only HPV-16, HPV-18, HPV-6 and HPV-11. Further investigations should be continued for the establishment of vaccine that matches all genotypes circulating in the country. © 2010 Elsevier B.V.
Authors & Co-Authors
Djigma, Florencia Wendkuuni
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Ouédraogo, Charlemagne Marie Ragnag Néwendé
Burkina Faso, Ouagadougou
University of Ouagadougou
Karou, Simplice Damintoti
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Togo, Lome
Centre Hospitalier Universitaire Tokoin
Sagna, Tani
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Bisseyé, Cyrille
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Zeba, Moctar Tokèda Abdoul
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Ouermi, Djénéba
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Gnoula, Charlemagne
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Pietra, Virginio
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Italy, Brescia
Università Degli Studi Di Brescia
Ghilat-Avoid-Belem, N. W.
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Sanogo, K.
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Sempore, Judith Nomwende
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Pignatelli, Salvatore
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Ferri, A. M.
Italy, Rome
Sapienza Università Di Roma
Nikiéma, Jean Baptiste
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Simpore, J.
Burkina Faso, Ouagadougou
Labiogene Ufr/svt
Burkina Faso, Ouagadougou
University of Ouagadougou
Statistics
Citations: 32
Authors: 16
Affiliations: 5
Identifiers
Doi:
10.1016/j.actatropica.2010.12.007
ISSN:
0001706X
Research Areas
Cancer
Genetics And Genomics
Infectious Diseases
Sexual And Reproductive Health
Study Design
Cross Sectional Study
Study Locations
Burkina Faso
Participants Gender
Female